McAlpineI. Porphyria—a royal malady. London: British Medical Journal Publication1968.
2.
BrodieMJMooreMRGoldbergA. The enzyme abnormalities in the porphyrias. Lancet1977; 2: 699–701.
3.
MooreMRMcCollKELGoldbergA. The porphyrias. Diabetes and Metabolism1979; 5: 323–336.
4.
WatsonCJPierachCABossenmaierICardinalR. Use of haematin in the acute attack of the ‘inducible’ hepatic porphyrias. Adv Intern Med1978; 23: 265–286.
5.
MooreMR. International review of drugs in acute porphyria. Int J Biochem1980; 12: 1089–1097.
6.
McCollKELThompsonGGMooreMRGoldbergA. Haematin therapy and leucocyte delta-aminolaevulinic acid synthetase activity in prolonged attack of acute porphyria. Lancet1979; 1: 133–134.
7.
LamonJMFrykholmBCHessRATschudyDP. Haematin therapy for acute porphyria. Medicine1979; 58: 252–269.
8.
DharGJBossenmaierICardinalRPetrykaZJWatsonCJ. Transitory renal failure following rapid administration of a relatively large amount of haematin in a patient with acute intermittent porphyria in clinical remission. Acta Med Scand1978; 203: 437–443.
9.
BrodieMJMooreMRThompsonGGGoldbergALowRAL. Pregnancy and the acute porphyrias. Br J Obstet Gynaecol1977; 84: 726–731.
10.
LamonJMFrykholmBCBennettMTschudyDP. Prevention of acute porphyric attacks by intravenous haematin. Lancet1978: 2: 492–494.
11.
LamonJMFrykholmBCTschudyDP. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthase. J Med Genet1979; 16: 134–139.
12.
IppenH. Treatment of porphyria cutanea tarda by phlebotomy. Semin Haematol1977; 14: 253–259.
13.
SwanbeckGWennerstenG. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy. Br J Dermatol1977; 97: 77–81.
14.
Mathews-RothMMPathakMAFitzpatrickTBHarberLHKassEM. Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Arch Dermatol1977; 113: 1229–1332.
15.
EalesL. The effects of canthaxanthin on the photocutaneous manifestations of porphyria. S Afr Med J1978; 53: 1050–1052.
